In this episode, Dr. Slavin joined by Shelly Cummings, MS, CGC Director of Myriad Oncology Medical Affairs, speak with Sue Friedman - Founder and Executive Director of the hereditary testing patient advocacy group, Facing Our Risk of Cancer Empowered - F.O.R.C.E. They discuss how FORCE was created, how it has been affected by COVID-19, and what initiatives are currently in the works.
Facing Our Risk Of Cancer Empowered - F.O.R.C.E. advocates for families facing hereditary breast and ovarian cancer in areas such as access to care, research funding, insurance, and privacy. Learn more here: https://www.facingourrisk.org/